BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35163138)

  • 1. Metabolomic Fingerprinting for the Detection of Early-Stage Lung Cancer: From the Genome to the Metabolome.
    Haince JF; Joubert P; Bach H; Ahmed Bux R; Tappia PS; Ramjiawan B
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Lung Cancer Detection.
    Inage T; Nakajima T; Yoshino I; Yasufuku K
    Clin Chest Med; 2018 Mar; 39(1):45-55. PubMed ID: 29433724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.
    Spiro SG; Shah PL; Rintoul RC; George J; Janes S; Callister M; Novelli M; Shaw P; Kocjan G; Griffiths C; Falzon M; Booton R; Magee N; Peake M; Dhillon P; Sridharan K; Nicholson AG; Padley S; Taylor MN; Ahmed A; Allen J; Ngai Y; Chinyanganya N; Ashford-Turner V; Lewis S; Oukrif D; Rabbitts P; Counsell N; Hackshaw A
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31537697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
    O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Metabolite Profiling in the Search for Early-Stage Biomarkers for Lung Cancer: Some Important Breakthroughs.
    Meynen J; Adriaensens P; Criel M; Louis E; Vanhove K; Thomeer M; Mesotten L; Derveaux E
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
    Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; La Vecchia C; Sozzi G; Pastorino U
    Oncotarget; 2015 Oct; 6(32):32868-77. PubMed ID: 26451608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of novel biological tools used in screening for the early detection of lung cancer.
    Ghosal R; Kloer P; Lewis KE
    Postgrad Med J; 2009 Jul; 85(1005):358-63. PubMed ID: 19581246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of lung cancer: role of biomarkers.
    Brambilla C; Fievet F; Jeanmart M; de Fraipont F; Lantuejoul S; Frappat V; Ferretti G; Brichon PY; Moro-Sibilot D
    Eur Respir J Suppl; 2003 Jan; 39():36s-44s. PubMed ID: 12572700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments and advances in secondary prevention of lung cancer.
    Rizzo S; Del Grande F; Wannesson L; Froesch P; Giannetto G; Petrella F
    Eur J Cancer Prev; 2020 Jul; 29(4):321-328. PubMed ID: 32452945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and early detection of lung cancer.
    Van't Westeinde SC; van Klaveren RJ
    Cancer J; 2011; 17(1):3-10. PubMed ID: 21263260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Diagnostics for Early Detection of Lung Cancer: Challenges and Potential with a Focus on Changes in DNA Methylation.
    Farooq M; Herman JG
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2416-2422. PubMed ID: 33148791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biomarkers for future screening of lung cancer.
    Hensing TA; Salgia R
    J Surg Oncol; 2013 Oct; 108(5):327-33. PubMed ID: 23893423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for lung cancer: Who should be screened?
    Jett J
    Arch Pathol Lab Med; 2012 Dec; 136(12):1511-4. PubMed ID: 23194043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular approaches to lung cancer prevention.
    Alam A; Ansari MA; Badrealam KF; Pathak S
    Future Oncol; 2021 May; 17(14):1793-1810. PubMed ID: 33653087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
    Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
    Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular sputum analysis for the diagnosis of lung cancer.
    Hubers AJ; Prinsen CF; Sozzi G; Witte BI; Thunnissen E
    Br J Cancer; 2013 Aug; 109(3):530-7. PubMed ID: 23868001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges.
    Seijo LM; Peled N; Ajona D; Boeri M; Field JK; Sozzi G; Pio R; Zulueta JJ; Spira A; Massion PP; Mazzone PJ; Montuenga LM
    J Thorac Oncol; 2019 Mar; 14(3):343-357. PubMed ID: 30529598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in early diagnosis of lung cancer].
    Liu Y; Wang M
    Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):429-34. PubMed ID: 21569649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic investigation of urinary extracellular vesicles for early detection and screening of lung cancer.
    Yang Q; Luo J; Xu H; Huang L; Zhu X; Li H; Yang R; Peng B; Sun D; Zhu Q; Liu F
    J Nanobiotechnology; 2023 May; 21(1):153. PubMed ID: 37189121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.